LICENSE AGREEMENTLicense Agreement • March 17th, 2008 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMarch 17th, 2008 Company IndustryThis Agreement is entered into as of December 10, 2005 (the “Effective Date”) by and between (i) SD Pharmaceuticals, Inc., a Delaware corporation (“SDP”), and (ii) Latitude Pharmaceuticals, Inc., a Delaware corporation (“LPI”), and (iii) Andrew X. Chen (“Dr. Chen”), with respect to the following facts:
January 28, 2008Separation Agreement • March 17th, 2008 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMarch 17th, 2008 Company Industry
Stock Option AgreementStock Option Agreement • March 17th, 2008 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMarch 17th, 2008 Company IndustryADVENTRX Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the undersigned person (“Optionee”) have entered into this Stock Option Agreement (this “Agreement”) effective as of the Grant Date set forth below. The Company has granted to Optionee the option (the “Option”) to purchase the number of shares (the “Shares”) of common stock, par value $0.001 per share, of the Company (“Common Stock”) set forth below at the per Share purchase price (the “Exercise Price”) set forth below, pursuant to the terms of this Agreement. The Option was granted under the Company’s 2005 Equity Incentive Plan (the “Plan”).